Search Results for "Recall Promus Heart Stent"

20:26 EDT 25th September 2016 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...


Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

Paclitaxel-eluting balloons reduce late lumen loss in coronary in-stent restenosis

In the prospective, randomized Treatment of In-Stent Restenosis study, use of paclitaxel-eluting balloons to treat bare metal stent restenosis yielded lower rates of late lumen loss at 12 months compa...

Arizona marathon runner receives first dissolvable heart stent

A dissolvable heart

Abbott Laboratories' absorbable heart stent wins FDA nod

Abbott Laboratories has obtained approval from the FDA for its Absorb heart stent, a polymer device that dissolves within thr -More- 

FDA Approves Abbott's Absorbable Heart Stent

The U.S. Food and Drug Administration approved Abbott Laboratories’ absorbable heart stent called Absorb, a device cardiologists say represents a significant advance in treatment of coronary artery ...

Abbott's heart stent wins approval from Canada

Abbott has obtained approval from Health Canada for its Absorb bioresorbable heart stent, a device that dissolves in three ye -More- 

Women undergoing PCI with newer DES have higher prevalence of chest pain

In a pooled analysis of the DUTCH PEERS and TWENTE randomized trials, the prevalence of clinically relevant chest pain was significantly higher among women undergoing PCI with newer-generation drug-el...

Abbott’s Absorb bioresorbable heart stent gets FDA approval

Healthcare firm Abbott has received approval from the US Food and Drug Administration (FDA) for its Absorb bioresorbable heart stent to market in the country.

FDA Approves Abbott' Absorbable Stent For Coronary Artery Disease

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) announced that the U.S. Food and Drug Administration has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device...

Matching PubMed Articles

Effects of Positive and Negative Mood Induction on the Prefrontal Cortex Activity Measured by Near Infrared Spectroscopy.

The neurophysiological mechanism of positive versus negative emotions is insufficiently understood. In the present study, we examined the effect of event recall tasks on the prefrontal cortex (PFC) ac...

Investigation of fibrous cap stresses on vulnerable plaques leading to heart attacks.

Rupture-prone plaques in the coronary arteries, called ``vulnerable plaques'', are recognized as the key factor in acute myocardial infarction. Vulnerable plaques have a thin fibrous cap over a large ...

Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.

Fibrin deposition and absent endothelium characterize unhealed stents that are at heightened risk of stent thrombosis. Optical coherence tomography (OCT) is increasingly used for assessing stent tissu...

Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?

The natural history and the role of atherosclerotic plaque located behind the stent (PBS) are still poorly understood. We evaluated the serial changes in PBS following bare-metal (BMS) compared to fir...

Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.

In-stent restenosis (ISR) remains an important concern despite the recent advances in the drug-eluting stent (DES) technology. The introduction of drug-eluting balloons (DEB) offers a good solution to...

Search Whole site using Google

Quick Search
Advertisement Advertisement